Sugi Predict

Sugi Predict / Compounds / SCHEMBL2893079

SCHEMBL2893079

SCHEMBL2893079

CC(C)(C)[Si](C)(C)OCCCc1nc2ccccc2c(N)c1N

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 0.39
▸ ALDH1A1 P00352 2/20 0.39
▸ GLA P06280 2/20 0.39
▸ HPGD P15428 2/20 0.39
▸ CASP1 P29466 2/20 0.39
▸ CASP7 P55210 2/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ HSD17B10 Q99714 2/20 0.39
▸ ACHE P22303 2/20 0.39
▸ CHRM2 P08172 1/20 0.39
▸ ADRA2A P08913 1/20 0.39
▸ ADORA3 P0DMS8 1/20 0.39
▸ CHRM1 P11229 1/20 0.39
▸ NQO2 P16083 1/20 0.39
▸ MAOA P21397 1/20 0.39
▸ DRD1 P21728 1/20 0.39
▸ SLC6A2 P23975 1/20 0.39
▸ ADRA1A P35348 1/20 0.39
▸ OPRM1 P35372 1/20 0.39
▸ KCNH2 Q12809 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4006060 0.96 KDM4E (0.38) KDM4EALDH1A1GLAHPGDCASP1
SCHEMBL5455544 0.81 ALDH1A1 (0.46) KDM4EALDH1A1GLAHPGDCASP1
SCHEMBL20766729 0.79 TACR1 (0.41) KDM4EALDH1A1GLAHPGDCASP1
SCHEMBL2368949 0.77 KDM4E (0.46) KDM4EALDH1A1GLAHPGDCASP1
SCHEMBL1140625 0.76 ACHE (0.34) KDM4EALDH1A1GLAHPGDCASP1
SCHEMBL1775764 0.75 HSD17B10 (0.37) KDM4EALDH1A1GLAHPGDCASP1
SCHEMBL15923395 0.74 KDM4E (0.55) KDM4EALDH1A1GLAHPGDCASP1
SCHEMBL2750294 0.73 TLR8 (0.37) LMNATLR8TLR7
SCHEMBL5356465 0.73 ACHE (0.50) KDM4EALDH1A1GLAHPGDCASP1
SCHEMBL2252126 0.73 IDO1 (0.53) MAOALMNAPOLBKMT2ADUT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130225555-A1 Imidazoquinolines with Immuno-Modulating Properties DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2013-08-29 — — US disclosed
US-8436178-B2 Imidazoquinolines with immuno-modulating properties ASTRAZENECA AB (SE) 2013-05-07 — — US disclosed
EP-2155743-B1 IMIDAZOQUINOLINES WITH IMMUNO-MODULATING PROPERTIES ASTRAZENECA AB (SE) 2012-08-29 — — EP disclosed
US-20100280001-A1 IMIDAZOQUINOLINES WITH IMMUNO-MODULATING PROPERTIES SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2010-11-04 — — US disclosed
EP-2155743-A1 IMIDAZOQUINOLINES WITH IMMUNO-MODULATING PROPERTIES AstraZeneca AB (SE) 2010-02-24 — — EP disclosed
WO-2008135791-A1 IMIDAZOQUINOLINES WITH IMMUNO-MODULATING PROPERTIES ASTRAZENECA AB (SE) 2008-11-13 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100280001-A1 IMIDAZOQUINOLINES WITH IMMUNO-MODULATING PROPERTIES IFNG, FCGRT, IFNAR1 KDM4E 1803/4885ALDH1A1 512/4885GLA 3826/4885
US-20130225555-A1 Imidazoquinolines with Immuno-Modulating Properties IFNG, FCGRT, IFNAR1 KDM4E 1803/4885ALDH1A1 512/4885GLA 3826/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.